Login
$QURE
$22.97 -$1.86 (7.49%) Close

Company Executives

Officer Age In this role Joined Pay Source
Matthew Kapusta Also a director
CEO, Managing Director
Title from the Form 4 dated Jul 2, 2026
53 Not stated Not stated Not reported
Christian Klemt
Chief Financial Officer
53 Since 2021
5 years
Not stated Not reported
Walid Abi-Saab
Chief Medical Officer
60 Since 2023
3 years
Not stated Not reported
Kylie O'Keefe
Chief Customer & Strat Officer
Title from the Form 4 dated Jun 11, 2026
41 Not stated 2025 Not reported
Jeannette Potts
Chief Legal Officer
Title from the Form 4 dated Jun 15, 2026
64 Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
6 of 7
stated in the proxy; 1 not stated
Average tenure
7.5 years
from year joined
CEO also chairs the board
No
David Meek
Director Age On board Independent Committees Other public boards 2025 pay Source
David Meek
62 2018
8 years
Not stated
Compensation Committee Nominating and Corporate Governance Committee Commercial Committee
Sobi, Cullinan Therapeutics (Nasdaq: CGEM) $364,671
Matthew Kapusta
53 Not stated Not independent None stated None stated Paid as CEO
Madhavan Balachandran
75 Not stated Independent
Compensation Committee · Chair Commercial Committee
None stated $332,171
Robert Gut
61 2018
8 years
Independent
Research & Development Committee
None stated $319,630
Rachelle Jacques
54 2021
5 years
Independent
Audit Committee Commercial Committee · Chair
Corbus Pharmaceuticals (Nasdaq: CRBP) $337,212
Jack Kaye
82 Not stated Independent
Audit Committee · Chair Compensation Committee
None stated $339,630
Leonard Post
73 Not stated Independent
Research & Development Committee · Chair
None stated $327,130
Jeremy Springhorn
63 2017
9 years
Independent
Nominating and Corporate Governance Committee · Chair Research & Development Committee
None stated $344,671

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 27, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support